 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Global Projects Implementation Center |
| Street 1: | 23/a Alexander Khazbegi av. Building 2, floor 5 |
| Street 2: | |
| City: | Tbilisi |
| Province: | |
| Post Code: | 0160 |
| Country: | Georgia |
| Phone: | +99532388220 |
| Email: | info@gpic.org.ge |
| Web Site: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Organization Type - Primary: | Non-Governmental Organization |
| Organization Type - Secondary: | Other Non-Governmental Organization (NGO) |
| Is your organization legally registered in your country: | |
| Organization Reach: | International |
| Organization Description: | |
| A Non Governmental, Non Commercial legal entity “Global Projects Implementation Center” (GPIC) , established on 25 January 2011, is a successor of Georgia Health and Social Projects' Implementation Center (GHSPIC) which implemented international and state projects and programs in the area of health care and social affairs; for 7 years it was a Principle Recipient of The Global Fund Grants. On 24 December, 2010, CCM Georgia made a decision to separate The Global Fund Projects Implementation team from the GHSPIC and to assign to this team legal status of the NGO and to make this new entity as a principle recipient for TGF grants. GPIC has undergone all necessary legal procedures from The Global Fund side and since 1 April 2011, became a Principle recipient of all GFATM grants in Georgia. Currently GPIC implements The Global Fund HIV/AIDS, Tuberculosis and malaria projects. |
|
| Total number of staff in your organization: | Unknown |
| Number of full-time staff who are directly involved with TB: | 1 - 5 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | Unknown |
| What is your organization's annual budget (USD) dedicated to TB? | $1 MIL-$10 MIL |
| How did you hear about the Stop TB Partnership: | Involvement in TB control provision |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
Geographical Reach | |
| Which country is your headquarters located in: | Georgia |
| Which WHO region is the main focus of your work: | European |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Georgia |
Specializations | |
|
Advocacy, communication and social mobilization Advocacy, communication and social mobilization Advocacy, communication and social mobilization Funding Funding Funding TB Healthcare Services TB Healthcare Services TB Healthcare Services Technical Assistance Technical Assistance Technical Assistance |
Specializations in Countries | |
| Funding | Georgia |
| TB Healthcare Services | Georgia |
| Technical Assistance | Georgia |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
DOTS Expansion and Enhancement: • Advocacy to sustain high political commitment for TB control in Country • Upgrade and supply TB laboratory network • Support the NTP to provide standardized treatment with DOT provision and incentives and enablers for patients • Uninterrupted supply of first line anti TB drugs • Support the NTP to monitor and evaluate program performance with regular supervisions at the regional and central levels Drug-Resistant TB: Support the NTP to sustain up access to testing for resistance to first-line anti-TB drugs among TB patients, with provision of laboratory equipment and consumables. • Support the NTP to sustain access to testing of susceptibility to second-line anti-TB drugs. • Support the NTP to provide effective treatment with DOT provision and incentives and enablers for patients • Support the NTP to improve infection control measures • Support the NTP to strengthen surveillance with timely transportation of sputum specimens TB-HIV: • Support the NTP to provide HIV testing among confirmed TB cases • Support the NTP to provide screening of TB cases among IDUs • Support the NTP ensure access to CPT for HIV positive TB patients • Support the NTP ensure access to IPT among people living with HIV and who do not have active TB according to international guidelines Laboratory Strengthening: • Support the NTP to sustain access to quality-assured AFB microscopy with effective external quality assurance • Support the NTP to sustain access to rapid laboratory diagnosis of drug-resistant TB • Support the NTP to sustain laboratory quality management systems |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | August 25, 2008 |
| Last updated: | September 24, 2011 |